1. Home
  2. NSPR vs BDL Comparison

NSPR vs BDL Comparison

Compare NSPR & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.00

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

HOLD

Current Price

$33.31

Market Cap

62.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
BDL
Founded
2005
1959
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
62.6M
IPO Year
2009
1995

Fundamental Metrics

Financial Performance
Metric
NSPR
BDL
Price
$1.00
$33.31
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
221.8K
1.2K
Earning Date
05-04-2026
05-18-2026
Dividend Yield
N/A
1.90%
EPS Growth
N/A
49.72
EPS
N/A
1.98
Revenue
$2,310,000.00
$205,248,000.00
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
$16.82
Revenue Growth
N/A
8.99
52 Week Low
$1.00
$26.33
52 Week High
$2.93
$35.98

Technical Indicators

Market Signals
Indicator
NSPR
BDL
Relative Strength Index (RSI) 28.19 58.17
Support Level N/A $28.82
Resistance Level $1.29 $33.69
Average True Range (ATR) 0.09 1.51
MACD -0.00 0.30
Stochastic Oscillator 9.38 84.18

Price Performance

Historical Comparison
NSPR
BDL

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

Share on Social Networks: